Safety and Immunogenicity of 2009 Pandemic H1N1 Influenza Vaccination in Perinatally HIV-1–Infected Children, Adolescents, and Young Adults

Background. The safety and immunogenicity of high-dose pandemic H1N1 (pH1N1) vaccination in perinatally human immunodeficiency virus type 1 (HIV-1)–infected children, adolescents, and young adults are unknown. Methods. Two 30-μg doses of 2009 Novartis pH1N1 monovalent vaccine (Fluvirin) were adminis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Flynn, Patricia M., Nachman, Sharon, Muresan, Petronella, Fenton, Terence, Spector, Stephen A., Cunningham, Coleen K., Pass, Robert, Yogev, Ram, Burchett, Sandra, Heckman, Barbara, Bloom, Anthony, Utech, L. Jill, Anthony, Patricia, Petzold, Elizabeth, Levy, Wende, Siberry, George K., Ebiasah, Ruth, Miller, Judi, Handelsman, Edward, Weinberg, Adriana
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2012
Matèries:
Major Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3490699/
https://ncbi.nlm.nih.gov/pubmed/22615311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jis360
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars